TY  - JOUR
T1  - Down syndrome Clinical features, and it's Associated Complications Evaluation and Management Approach
A1  - Abdullah Khalaf A Alshammar
A1  - Salma Sameer A Alkattan
A1  - Rahaf Mohammed S Alsharif
A1  - Nawaf Falah J Alwahbi
A1  - Kawther Ali A Alhussain
A1  - Ahmad Mohammed M Alqahtani
A1  - Abdulmajeed Hussain Saeedi
A1  - Mohammed Abdullah M Alhussain
A1  - Mohammad Hassan Haroobi
A1  - Muath Ali H Alshehri
A1  - Renad Sultan Alotaibi
JF  - Pharmacophore
JO  - Pharmacophore
SN  - 2229-5402
Y1  - 2021
VL  - 12
IS  - 4
DO  - 10.51847/n81OfVwvph
SP  - 103
EP  - 106
N2  - Trisomy 21 (T21), or Down syndrome (DS), is one of the major causes of intellectual disability, this has been analyzed to differ in every individual by the intelligence quotient (IQ) test irrespective of other factors. It is a genetic disorder characterized by an extra copy of chromosome 21. PubMed database was used for searching relevant papers, and the following keys were used in the mesh (("Down syndrome " [Mesh]) AND ("Features and diagnosis" [Mesh]) OR ("Down syndrome Features and diagnosis " [Mesh])). Inclusion criteria were all the articles that consisted of one of the following topics: Down syndrome Features and diagnosis. Concerning exclusion criteria, all articles which did not have one of the inclusion criteria as their topic was not selected. To date, nothing has been developed that effectively improves cognition in children with DS, but effective early stimulation therapy, behavioral intervention, a positive home environment, education, and vocational training are all useful in improving their overall functioning and productivity.
UR  - https://pharmacophorejournal.com/article/down-syndrome-clinical-features-and-its-associated-complications-evaluation-and-management-approac-o3fefk4qskk11qt
ER  -